Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -19.34% | 31.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.34% | 31.75% | |||
| Cost of Revenue | -26.37% | 16.76% | |||
| Gross Profit | -11.31% | 54.44% | |||
| SG&A Expenses | -12.14% | -2.15% | |||
| Depreciation & Amortization | -7.09% | 1.03% | |||
| Other Operating Expenses | 62.39% | 49.65% | |||
| Total Operating Expenses | -8.94% | 3.33% | |||
| Operating Income | 4.72% | 4.99% | |||
| Income Before Tax | 10.30% | 3.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.30% | 3.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -25.00% | -4.00% | |||
| Net Income | 10.24% | 3.47% | |||
| EBIT | 4.72% | 4.99% | |||
| EBITDA | 8.01% | 5.98% | |||
| EPS Basic | 19.31% | 20.95% | |||
| Normalized Basic EPS | 12.40% | 22.36% | |||
| EPS Diluted | 19.31% | 20.95% | |||
| Normalized Diluted EPS | 12.40% | 22.36% | |||
| Average Basic Shares Outstanding | 11.24% | 22.12% | |||
| Average Diluted Shares Outstanding | 11.24% | 22.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||